Health CanadaGeneral Alert
DARZALEX (daratumumab) and Hepatitis B Virus Reactivation
Published: March 25, 2019Recall ID: 59512Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
DARZALEX (daratumumab) and Hepatitis B Virus Reactivation
Additional Source Details
| Field | Value |
|---|---|
| N I D | 59512 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/darzalex-daratumumab-and-hepatitis-b-virus-reactivation |
| Issue | Product safety |
| Title | DARZALEX (daratumumab) and Hepatitis B Virus Reactivation |
| Archived | 0 |
| Category | Biologic or vaccine |
| Last updated | 2019-03-25 |
| Organization | Marketed health products |